Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system

Yuen Sum Lau, Yiu K. Fung

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

In mice, chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces an increase in the maximum number of [3H]spiperone binding sites in the striatum. The sensitivity of striatal protein phosphorylation to calcium plus calmodulin is also potentiated in MPTP-treated mice. These observations are associated with an enhancement of apomorphine-induced climbing behavior in the drug-treated animals. The results of this study suggest that in an animal model for Parkinson's disease, MPTP interrupts the dopamine (DA) transmission by chemically denervating the nigrostriatal neurons and through a compensatory mechanism, it increases the number of DA receptors as well as the sensitivity of protein phosphorylation to calcium plus calmodulin in mouse striatum. The latter two events may contribute to the development of DA receptor supersensitivity.

Original languageEnglish (US)
Pages (from-to)311-315
Number of pages5
JournalBrain Research
Volume369
Issue number1-2
DOIs
StatePublished - Mar 26 1986

Fingerprint

Corpus Striatum
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Dopamine Receptors
Pharmacology
Calmodulin
Phosphorylation
Calcium
Spiperone
Apomorphine
Parkinson Disease
Dopamine
Proteins
Animal Models
Binding Sites
Neurons
Pharmaceutical Preparations

Keywords

  • 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
  • [H]spiperone binding site
  • apomorphine-stimulated-climbing behavior
  • calmodulin-dependent phosphorylation
  • dopamine receptor supersensitivity
  • striatum

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system. / Lau, Yuen Sum; Fung, Yiu K.

In: Brain Research, Vol. 369, No. 1-2, 26.03.1986, p. 311-315.

Research output: Contribution to journalArticle

@article{226d553b760347cf8e4b54a0a7705b42,
title = "Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system",
abstract = "In mice, chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces an increase in the maximum number of [3H]spiperone binding sites in the striatum. The sensitivity of striatal protein phosphorylation to calcium plus calmodulin is also potentiated in MPTP-treated mice. These observations are associated with an enhancement of apomorphine-induced climbing behavior in the drug-treated animals. The results of this study suggest that in an animal model for Parkinson's disease, MPTP interrupts the dopamine (DA) transmission by chemically denervating the nigrostriatal neurons and through a compensatory mechanism, it increases the number of DA receptors as well as the sensitivity of protein phosphorylation to calcium plus calmodulin in mouse striatum. The latter two events may contribute to the development of DA receptor supersensitivity.",
keywords = "1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), [H]spiperone binding site, apomorphine-stimulated-climbing behavior, calmodulin-dependent phosphorylation, dopamine receptor supersensitivity, striatum",
author = "Lau, {Yuen Sum} and Fung, {Yiu K.}",
year = "1986",
month = "3",
day = "26",
doi = "10.1016/0006-8993(86)90541-X",
language = "English (US)",
volume = "369",
pages = "311--315",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system

AU - Lau, Yuen Sum

AU - Fung, Yiu K.

PY - 1986/3/26

Y1 - 1986/3/26

N2 - In mice, chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces an increase in the maximum number of [3H]spiperone binding sites in the striatum. The sensitivity of striatal protein phosphorylation to calcium plus calmodulin is also potentiated in MPTP-treated mice. These observations are associated with an enhancement of apomorphine-induced climbing behavior in the drug-treated animals. The results of this study suggest that in an animal model for Parkinson's disease, MPTP interrupts the dopamine (DA) transmission by chemically denervating the nigrostriatal neurons and through a compensatory mechanism, it increases the number of DA receptors as well as the sensitivity of protein phosphorylation to calcium plus calmodulin in mouse striatum. The latter two events may contribute to the development of DA receptor supersensitivity.

AB - In mice, chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces an increase in the maximum number of [3H]spiperone binding sites in the striatum. The sensitivity of striatal protein phosphorylation to calcium plus calmodulin is also potentiated in MPTP-treated mice. These observations are associated with an enhancement of apomorphine-induced climbing behavior in the drug-treated animals. The results of this study suggest that in an animal model for Parkinson's disease, MPTP interrupts the dopamine (DA) transmission by chemically denervating the nigrostriatal neurons and through a compensatory mechanism, it increases the number of DA receptors as well as the sensitivity of protein phosphorylation to calcium plus calmodulin in mouse striatum. The latter two events may contribute to the development of DA receptor supersensitivity.

KW - 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

KW - [H]spiperone binding site

KW - apomorphine-stimulated-climbing behavior

KW - calmodulin-dependent phosphorylation

KW - dopamine receptor supersensitivity

KW - striatum

UR - http://www.scopus.com/inward/record.url?scp=0022549418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022549418&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(86)90541-X

DO - 10.1016/0006-8993(86)90541-X

M3 - Article

C2 - 3486026

AN - SCOPUS:0022549418

VL - 369

SP - 311

EP - 315

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -